Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Resmed Inc
NYSE:RMD
Resmed Inc
NYSE:RMD
Price:
232.67
USD
-7.97%
Market Closed
Market Cap:
$33.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Resmed Inc
NYSE:RMD
|
US |
|
Airbus SE
XETRA:AIR
|
NL |
|
Aegon NV
OTC:AEGOF
|
NL |
Wall St Price Targets
RMD Price Forecast
Based on 19 analysts
Based on 19 analysts
+5% Upside
from
$232.67
today
Resmed Inc (RMD)’s 12-month stock price forecast through October 2027 has a consensus target of $244.8, implying 5% upside. The forecast is based on price targets from 19 Wall Street analysts.
RMD Analyst Rating
Based on 20 analysts
Based on 20 analysts
Analysts rate RMD Buy, with 9 of 20 recommending Buy or Strong buy.
Resmed Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RMD's stock price target?
Price Target
244.8
USD
244.8
USD
According to Wall Street analysts, the average 1-year price target for RMD is 244.8 USD with a low forecast of 176.75 USD and a high forecast of 336 USD.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
6%
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
7%
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
8%
8%
Over the last 14 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 8%.
What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
9%
9%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
9%
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 9%.